Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China flag China · Delayed Price · Currency is CNY
31.70
-0.43 (-1.34%)
May 19, 2026, 4:00 PM EDT

SHE:301246 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
317.19472.74745.59421.86395.19120.43
Short-Term Investments
--379.25292.3190-
Trading Asset Securities
1,2751,128900.321,466--
Cash & Short-Term Investments
1,5921,6012,0252,180485.19120.43
Cash Growth
-1.77%-20.95%-7.10%349.31%302.89%-55.02%
Accounts Receivable
987.34904.42559.44602.64660.21458.16
Other Receivables
47.0246.779.89141.6787.645.85
Receivables
1,034951.12639.33744.3747.8504.01
Inventory
334.9319.01270.53191.51352.95384.48
Other Current Assets
379.11425.86111.3486.4378.9820.72
Total Current Assets
3,3413,2973,0463,2021,6651,030
Property, Plant & Equipment
2,3332,3642,2921,9101,620891.27
Long-Term Investments
230.56211.24203.64228.08335.12242.35
Other Intangible Assets
177.47178.84181.89183.06173.62194.15
Long-Term Deferred Tax Assets
19.6319.6617.2617.5621.2217.72
Long-Term Deferred Charges
3.574.085.525.956.8611.98
Other Long-Term Assets
178.5789.5978.06103.953.2745.14
Total Assets
6,2836,1655,8255,6513,8752,432
Accounts Payable
725.61798.99777.27636.79934.95340.92
Accrued Expenses
13.9534.0855.2857.5465.757.98
Short-Term Debt
70.7460.0459.32-17.6420.1
Current Portion of Long-Term Debt
99.4396.5777.0165.966.092.84
Current Portion of Leases
--0.740.60.560.53
Current Income Taxes Payable
28.8927.233.561.1538.2945.65
Current Unearned Revenue
30.0419.7913.8719.831.0129.66
Other Current Liabilities
189.51204.51148.94133.04165.66120.05
Total Current Liabilities
1,1581,2411,136914.831,320617.73
Long-Term Debt
424.67368.34230.36276.12341.6747.22
Long-Term Leases
6.336.427.166.98.198.23
Long-Term Unearned Revenue
64.8168.0868.6471.5570.4560.8
Long-Term Deferred Tax Liabilities
21.8321.7321.6221.5421.3120.3
Total Liabilities
1,6761,7061,4641,2911,762754.27
Common Stock
400.01400.01400.01400.01352.75352.75
Additional Paid-In Capital
2,1812,1772,1722,17222.1520.62
Retained Earnings
2,0691,9251,8181,7861,7391,304
Treasury Stock
-47.15-47.15-32.8---
Comprehensive Income & Other
5.534.973.371.8900.46
Total Common Equity
4,6084,4604,3614,3602,1141,678
Minority Interest
-0.88-0.730.47---
Shareholders' Equity
4,6084,4594,3614,3602,1141,678
Total Liabilities & Equity
6,2836,1655,8255,6513,8752,432
Total Debt
601.17531.36374.59349.51434.1478.92
Net Cash (Debt)
991.061,0701,6511,83151.0541.51
Net Cash Growth
-13.10%-35.20%-9.83%3485.91%22.99%-62.14%
Net Cash Per Share
2.502.694.144.720.140.12
Filing Date Shares Outstanding
396.78409.17396.81399.9400.01352.75
Total Common Shares Outstanding
396.78409.17397.89400.01352.75352.75
Working Capital
2,1822,0561,9102,287345.02411.91
Book Value Per Share
11.6110.9010.9610.905.994.76
Tangible Book Value
4,4314,2814,1794,1771,9401,484
Tangible Book Value Per Share
11.1710.4610.5010.445.504.21
Buildings
--833.02719.62395.96329.31
Machinery
--1,6491,470782.58657
Construction In Progress
--630.57375.86946.39334.11
Source: S&P Global Market Intelligence. Standard template. Financial Sources.